Pacific Biosciences of California (PACB) PT Raised to $13 at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| PACIFIC BIO CA (NASDAQ: PACB) | Delayed: 2.67 +0.12 (4.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.55 | 52 Week High | $14.00 | |||
| Open | $2.24 | 52 Week Low | $6.61 | |||
| Day High | $2.69 | P/E | N/A | |||
| Day Low | $2.23 | EPS | $-1.26 | |||
| Volume | 3,172,328 | |||||
